Obesity drugs show promise for treating a new ailment: migraine

1 min read Original article ↗
  • NEWS

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs might treat. In a small study, the drug liraglutide reduced monthly migraine episodes by nearly half among people with obesity who experience the headache-inducing condition.

References

  1. Braca, S. et al. Headache https://doi.org/10.1111/head.14991 (2025).

    Article  Google Scholar 

  2. Botfield, H. F. et al. Sci. Transl. Med. 9, eaan0972 (2017).

    Article  PubMed  Google Scholar 

  3. Mitchell, J. L. et al. Brain 146, 1821–1830 (2023).

    Article  PubMed  Google Scholar 

Download references